$2.01B
Deals
$274.03M
Series A
71
New Companies
CipherBio Weekly Digest: Week of Feb 17 – Feb 23, 2022
Table of Contents
Top 5 Deals This Week
Minded, New York-based digital health/AI company, raises $25M in Seed round from various investors.
Plexium raises $102M in Series A led by
BVF Partners, L.P. and TCG X.
Equip Health raises $58M in Series B led by
The Chernin Group. In Series E
Somatus raises $325M led by
Wellington Management.
Sirona Medical acquires
Nines for an undisclosed amount.
Company | Round | Amount |
---|---|---|
Seed | $25M | |
Series A | $102M | |
Series B | $58M | |
Series E | $325M | |
Acquisition | Undisclosed |
Top Deals by Product and Clinical Phases
NovelMed announces phase 1 clinical trial of NM8074. In phase 2
Evelo Biosciences announces trial of EDP1815 in Atopic Dermatitis. Belgium-based
Pharmazz announces phase 3 clinical trial of Sovateltide for ischemic stroke. Senseonics announces FDA approval of Eversense E3 CGM System.
Company | Product and Clinical Phase | Indications |
---|---|---|
NM8074, Phase 1 | Paroxysmal Nocturnal Hemoglobinuria (PNH) | |
EDP1815, Phase 2 | Atopic Dermatitis, Allergic Diseases | |
Sovateltide, Phase 3 | Ischemic Stroke | |
Pure-Vu® EVS System, FDA Cleared | Diabetes |
71 Life Science Companies Added
This week we added 71 life science companies to our platform.
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.